Selvedge Venture is a venture capital firm headquartered in London, UK, specializing in investments aimed at alleviating the healthcare burden caused by age-related medical conditions. The firm focuses on early-stage companies—specifically Pre-Seed, Seed, and Series A stages—that are developing technologies at the intersection of biotechnology and digital technologies. Their primary areas of interest include metabolic syndrome (cardiovascular disease, diabetes, fatty liver disease, and obesity), cancer, and neurodegenerative diseases. Selvedge Venture's core expertise lies in leveraging biotechnology, machine learning tools, and integrated data assets to transform patient outcomes in these domains.
Is Selvedge Venture the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Selvedge Venture, along with a list of other relevant VCs, is available on Hopohopo.io.
Investment role
Lead and follow
Stages
Pre-seed, Seed, Series A
First ticket size
£100,000 - £5,000,000
When reaching out to Selvedge Venture, founders should highlight how their solution leverages advanced data science or machine learning to address complex healthcare challenges, especially those with clear translational potential. Demonstrating a strong scientific foundation, a credible path to clinical validation, and a clear understanding of regulatory and reimbursement landscapes will resonate. Emphasize how your technology can create measurable impact in patient outcomes and scalability across multiple disease areas, as Selvedge values platforms with broad applicability.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.